These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 30950936

  • 1. Inhibition of soluble epoxide hydrolase regulates monocyte/macrophage polarization and improves neurological outcome in a rat model of ischemic stroke.
    Yeh CF, Chuang TY, Hung YW, Lan MY, Tsai CH, Huang HX, Lin YY.
    Neuroreport; 2019 May 22; 30(8):567-572. PubMed ID: 30950936
    [Abstract] [Full Text] [Related]

  • 2. Soluble Epoxide Hydrolase Inhibitor Ameliorates Olfactory Dysfunction, Modulates Microglia Polarization, and Attenuates Neuroinflammation after Ischemic Brain Injury.
    Yeh CF, Chuang TY, Lan MY, Lin YY, Huang WH, Hung YW.
    J Neuroimmune Pharmacol; 2024 Oct 17; 19(1):54. PubMed ID: 39417923
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Soluble epoxide hydrolase inhibition enhances anti-inflammatory and antioxidative processes, modulates microglia polarization, and promotes recovery after ischemic stroke.
    Yeh CF, Chuang TY, Hung YW, Lan MY, Tsai CH, Huang HX, Lin YY.
    Neuropsychiatr Dis Treat; 2019 Oct 17; 15():2927-2941. PubMed ID: 31686827
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W, Koerner IP, Noppens R, Grafe M, Tsai HJ, Morisseau C, Luria A, Hammock BD, Falck JR, Alkayed NJ.
    J Cereb Blood Flow Metab; 2007 Dec 17; 27(12):1931-40. PubMed ID: 17440491
    [Abstract] [Full Text] [Related]

  • 7. Blockade of soluble epoxide hydrolase attenuates post-ischemic neuronal hyperexcitation and confers resilience against stroke with TrkB activation.
    Chang LH, Lin HC, Huang SS, Chen IC, Chu KW, Chih CL, Liang YW, Lee YC, Chen YY, Lee YH, Lee IH.
    Sci Rep; 2018 Jan 08; 8(1):118. PubMed ID: 29311641
    [Abstract] [Full Text] [Related]

  • 8. Genetic deletion or pharmacological inhibition of soluble epoxide hydrolase reduces brain damage and attenuates neuroinflammation after intracerebral hemorrhage.
    Wu CH, Shyue SK, Hung TH, Wen S, Lin CC, Chang CF, Chen SF.
    J Neuroinflammation; 2017 Nov 25; 14(1):230. PubMed ID: 29178914
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
    Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, Luria A, Hammock BD, Imig JD.
    Clin Sci (Lond); 2009 Jan 25; 116(1):61-70. PubMed ID: 18459944
    [Abstract] [Full Text] [Related]

  • 11. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
    Wu HF, Yen HJ, Huang CC, Lee YC, Wu SZ, Lee TS, Lin HC.
    J Biomed Sci; 2015 Oct 22; 22():94. PubMed ID: 26494028
    [Abstract] [Full Text] [Related]

  • 12. Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke.
    Shaik JS, Ahmad M, Li W, Rose ME, Foley LM, Hitchens TK, Graham SH, Hwang SH, Hammock BD, Poloyac SM.
    Am J Physiol Heart Circ Physiol; 2013 Dec 01; 305(11):H1605-13. PubMed ID: 24043255
    [Abstract] [Full Text] [Related]

  • 13. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
    Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD.
    Hypertension; 2005 Oct 01; 46(4):975-81. PubMed ID: 16157792
    [Abstract] [Full Text] [Related]

  • 14. Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.
    Kim IH, Nishi K, Tsai HJ, Bradford T, Koda Y, Watanabe T, Morisseau C, Blanchfield J, Toth I, Hammock BD.
    Bioorg Med Chem; 2007 Jan 01; 15(1):312-23. PubMed ID: 17046265
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M, Löhr L, Gelep J, Haverkamp W, Schunck WH, Gollasch M, Wutzler A.
    Cardiovasc Toxicol; 2019 Aug 01; 19(4):365-371. PubMed ID: 30725262
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Epoxyeicosanoid Signaling Provides Multi-target Protective Effects on Neurovascular Unit in Rats After Focal Ischemia.
    Liu Y, Wan Y, Fang Y, Yao E, Xu S, Ning Q, Zhang G, Wang W, Huang X, Xie M.
    J Mol Neurosci; 2016 Feb 01; 58(2):254-65. PubMed ID: 26545915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic effects of the soluble epoxide hydrolase (sEH) inhibitor AUDA on atherosclerotic diseases.
    Zhang J, Liu YS, Lu QH.
    Pharmazie; 2015 Jan 01; 70(1):24-8. PubMed ID: 25975094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.